0.2% chlorhexidine acetate as skin disinfectant prevents skin lesions in extremely preterm infants: A preliminary report

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 103, Issue 2, 2018, Pages F97-F100

  Janssen, Lisanne M A ^a   Tostmann, Alma ^a   Hopman, Joost ^a   Liem, Kian D ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

alcohol; burns; central line associated bloodstream infection; chlorhexidine gluconate; skin lesions

Indexed keywords

CEFTAZIDIME; CHLORHEXIDINE ACETATE; VANCOMYCIN; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BLISTER; CATHETER INFECTION; COHORT ANALYSIS; EDEMA; ELECTRONIC PATIENT RECORD; ERYTHEMA; GESTATIONAL AGE; HUMAN; INFANT; NEONATAL INTENSIVE CARE UNIT; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN DISEASE; SKIN INDURATION; ANALOGS AND DERIVATIVES; CENTRAL VENOUS CATHETER; CROSS INFECTION; ELECTRONIC HEALTH RECORD; FEMALE; MALE;

ANTI-INFECTIVE AGENTS, LOCAL; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; CROSS INFECTION; ELECTRONIC HEALTH RECORDS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; RETROSPECTIVE STUDIES; SKIN DISEASES;

EID: 85025820662     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2017-312694     Document Type: Article

References (26)

1. Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008;46:274-81.
2. O'Grady N P, Alexander M, Burns LA, et al; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011;39:S1-S34.
3. Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010;31:846-9.
4. Schick JB, Milstein JM. Burn hazard of isopropyl alcohol in the neonate. Pediatr 1981;68:587-8.
5. Reynolds PR, Banerjee S, Meek JH. Alcohol burns in extremely low birthweight infants: still occurring. Arch Dis Child Fetal Neonatal Ed 2005;90:F10.
6. Upadhyayula S, Kambalapalli M, Harrison CJ. Safety of anti-infective agents for skin preparation in premature infants. Arch Dis Child 2007;92:646-7.
7. Mannan K, Chow P, Lissauer T, et al. Mistaken identity of skin cleansing solution leading to extensive chemical burns in an extremely preterm infant. Acta Paediatr 2007;96:1536-7.
8. Garland JS, Alex C P, Mueller CD, et al. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. Pediatr Infect Dis J 1996;15:912-4.
9. Bringué Espuny X, Soria X, Solé E, et al. Chlorhexidine-methanol burns in two extreme preterm newborns. Pediatr Dermatol 2010;27:676-8.
10. Lashkari H P, Chow P, Godambe S. Aqueous 2% chlorhexidine-induced chemical burns in an extremely premature infant. Arch Dis Child Fetal Neonatal Ed 2012;97:F64.
11. Garland JS, Alex C P, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatr 2001;107:1431-6.
12. Watkins AM, Keogh EJ. Alcohol burns in the neonate. J Paediatr Child Health 1992;28:306-8.
13. Sardesai SR, Kornacka MK, Walas W, et al. Iatrogenic skin injury in the neonatal intensive care unit. J Matern Fetal Neonatal Med 2011;24:197-203.
14. Weitz NA, Lauren C T, Weiser JA, et al. Chlorhexidine gluconate-impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases. JAMA Dermatol 2013;149:195-9.
15. Fraise A P, Wilkinson MA, Bradley CR, et al. The antibacterial activity and stability of acetic acid. J Hosp Infect 2013;84:329-31.
16. Garland JS, Alex C P, Uhing MR, et al. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009;29:808-13.
17. Langer S, Sedigh Salakdeh M, Goertz O, et al. The impact of topical antiseptics on skin microcirculation. Eur J Med Res 2004;9:449-54.
18. Visscher M, deCastro M V, Combs L, et al. Effect of chlorhexidine gluconate on the skin integrity at PICC line sites. J Perinatol 2009;29:802-7.
19. Nachman RL, Esterly NB. Increased skin permeability in preterm infants. J Pediatr 1971;79:628-32.
20. Kalia YN, Nonato LB, Lund CH, et al. Development of skin barrier function in premature infants. J Invest Dermatol 1998;111:320-6.
21. Cartlidge P. The epidermal barrier. Semin Neonatol 2000;5:273-80.
22. Johnson J, Bracken R, Tamma PD, et al. Trends in chlorhexidine use in US neonatal intensive care units: results from a follow-up national survey. Infect Control Hosp Epidemiol 2016;37:1116-8.
23. Shah D, Tracy M. Skin antisepsis survey in Australia-New Zealand neonatal nurseries. J Paediatr Child Health 2013;49:601-2.
24. Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012;32:4-9.
25. Hibbard JS, Mulberry GK, Brady AR. A clinical study comparing the skin antisepsis and safety of ChloraPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine. J Infus Nurs 2002;25:244-9.
26. Loveday H P, Wilson JA, Pratt RJ, et al. epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2014;86:S1-S70.